Skip to main content

Advertisement

Table 1 Baseline characteristics of participants

From: Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer

  Participants Non-participants P-value
Gender, No. (%) men 45 (63) 29 (44.6) 0.04
Age, mean (SD, range) years 63 (11.5, 24–86) 65 (11.7, 26–80) 0.29
BMI, mean (SD) kg/m2 25.5 (4.5) 26.2 (5.6) 0.43
Socioeconomic status, mean (SD) score 0.44 (1.08) 0.23 (1.00) 0.24
EORTC-QLQ-C30 physical function, mean (SD) score 78 (21.7)   
ECOG/WHO performance score (PS), No. (%) 0.24
 0 25 (35) 23 (35)  
 1 25 (35) 29 (45)  
 2 22 (31) 13 (20)  
Tumor type, No. (%) 0.73
 Colorectal 16 (22) 12 (19)  
 Melanoma 13 (18) 21 (32)  
 Breast cancer 13 (18) 8 (12)  
 Prostate cancer 6 (8) 5 (8)  
 Gastric cancer 4 (6) 0 (0)  
 Pancreatic cancer 4 (6) 0 (0)  
 Other 15 (21) 19 (29)  
Current active treatment type, No. (%)a 0.17
 Chemotherapy 43 (61) 32 (49)  
 Targeted therapy 25 (35) 3 (5)  
 Immunotherapy 12 (17) 21 (32)  
 Hormonal therapy 4 (6) 1 (2)  
 No therapy 4 (6) 3 (5)  
Localized cancer treated with curative intention, No. (%) 5 (7) 7 (11) 0.43
  1. BMIbody mass index, EORTC-QLQ-C30 European Organisation for Research and Treatment of Cancer-Quality-Quality of Life Questionnaire-30 item module, ECOG/WHO Eastern Cooperative Oncology Group/World Health Organization a: Due to combination of therapies, the total percentage exceeds 100%